MHRA plans to launch an Early Access service, allowing patients quicker access to innovative medical devices addressing unmet NHS needs before full regulatory approval. Initially focusing on diagnostic devices, this service supports the UK’s Life Sciences Sector Plan and broader regulatory reforms, aiming to strengthen post-market surveillance and international collaboration in medical device innovation.